The delisting is a significant negative catalyst that will likely pressure the stock as U.S.-only holders exit and liquidity shifts to OTC. Monitor the appeal hearing timeline and any potential reverse stock split or other bid-price compliance efforts. The TSX listing provides a floor but does not offset the Nasdaq loss for U.S.-focused traders.
Price Chart
Executive Summary
Zentek announced its common shares will be delisted from the Nasdaq Capital Market and transition to the OTC Markets Group on September 2, 2026, due to non-compliance with the minimum bid price requirement. The company intends to appeal the delisting determination, but the hearing will not stay the suspension. Shares will continue trading on the TSX Venture Exchange, which is unaffected. This is a material negative event that reduces liquidity, visibility, and institutional accessibility for U.S. investors, though the company's primary listing remains intact.
Key Facts
- Zentek's common shares will be delisted from the Nasdaq Capital Market and transition to OTC Markets Group on September 2, 2026.
- Delisting is due to non-compliance with Nasdaq's minimum bid price requirement.
- Zentek intends to request a hearing to appeal the delisting determination, but the hearing will not stay the suspension.
- Shares will continue trading on the TSX Venture Exchange under symbol ZEN, which is unaffected.
- Zentek has applied for quotation on the OTCQX Best Market tier.
- The company states the transition is not expected to result in material impacts to business or operations.
Financial Impact
Loss of Nasdaq listing — reduced liquidity, potential forced selling by institutional holders with Nasdaq-only mandates, and diminished U.S. investor accessibility. No specific dollar impact stated.
Risk Factors
- Appeal may be denied, making delisting permanent.
- Reduced liquidity on OTC Markets could lead to wider bid-ask spreads and price volatility.
- Institutional investors with Nasdaq-only mandates may be forced to sell.
- No guarantee of OTCQX approval; shares may trade on lower OTC tiers.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (ZTEK) — Batch item 1 | 0001062993-26-004710 |
| Document: 0001062993-26-004710-index-headers.html | 0001062993-26-004710 |
| Document: 0001062993-26-004710-index.html | 0001062993-26-004710 |
| Document: 0001062993-26-004710.txt | 0001062993-26-004710 |
| 6-K Filing (ZTEK) — Batch item 5 | 0001062993-26-004710 |
| Document: 0001062993-26-004710-index-headers.html | 0001062993-26-004710 |
| Document: 0001062993-26-004710-index.html | 0001062993-26-004710 |
| Document: 0001062993-26-004710.txt | 0001062993-26-004710 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | 6-K | — | awaiting T+20 | — | — |
Aug 31, 2026 8w ago | 6-K | $0.5180 | awaiting T+20 | — | — |
Aug 28, 2026 8w ago | 6-K | $0.5200 | awaiting T+20 | — | — |
Aug 21, 2026 9w ago | 6-K | $0.6030 | awaiting T+20 | — | — |
Aug 20, 2026 9w ago | 6-K | $0.6049 | awaiting T+20 | — | — |
Aug 10, 2026 11w ago | 6-K | $0.6757 | awaiting T+20 | — | — |
Jul 20, 2026 14w ago | 6-K | $0.4601 $0.5950 | ▲ +29.32% | ▲ +25.20% | — |
Jul 15, 2026 14w ago | 6-K | $0.4950 $0.6292 | ▲ +27.11% | ▲ +24.77% | — |
Jul 7, 2026 16w ago | 6-K | $0.5138 $0.6739 | ▲ +31.16% | ▲ +29.83% | — |
Jun 29, 2026 17w ago | 6-K | $0.4620 $0.5316 | ▲ +15.06% | ▲ +15.34% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers